Recurrent Guillian Barre’ Syndrome vs acute onset CIDP - study of 2 cases.
DOI:
https://doi.org/10.17161/rrnmf.v5i1.20953Keywords:
Recurrent GBS, Acute onset CIDP, Paranodopathies, RituximabAbstract
The most common acquired immune mediated polyneuropathies are acute inflammatory demyelinating polyradiculoneuropathy(AIDP), a form of Gullian Barre syndrome (GBS) and chronic inflammatory demyelinating polyradiculoneuropathy(CIDP). Sixteen percent of CIDP patients may present acutely like AIDP, developing in less than 8 weeks. Also GBS which is usually monophasic can have recurrences . Distinguishing Acute onset CIDP(A-CIDP) and recurrent AIDP may be difficult in early stages but may be crucial to guide the treatment strategies.
Metrics
Downloads
References
Grand’Maison F, Feasby TE, Hahn AF, et al. Recurrent Guillain–Barre´ syndrome. Clinical and laboratory features. Brain 1992;115:1093–1106.
Das A, Kalita J, Misra UK. Recurrent Guillain–Barre´ syndrome. Electromyogr Clin Neurophysiol 2004;44:95–10
Latov N. Diagnosis and treatment of chronic acquired demyelinating polyneuropathies. Nat Rev Neurol. 2014;10:435–446. doi: 10.1038/nrneurol.2014.117.
Dalakas MC. Advances in the diagnosis, pathogenesis and treatment of CIDP. Nat. Rev. Neurol. 2011;7:507–517. doi: 10.1038/nrneurol.2011.121
Ruts L, Drenthen J, Jacobs BC, van Doorn PA; Dutch GBS Study Group. Distinguishing acute-onset CIDP from fluctuating Guillain-Barre syndrome: a prospective study. Neurology. 2010 May;74(21):1680–6.
Sejvar JJ, Baughman AL, Wise M, Morgan OW. Population incidence of Guillain-Barré syndrome: a systematic review and meta-analysis. Neuroepidemiology. 2011;36(2):123–33.
Jacobs BC, Rothbarth PH, van der Meché FG, Herbrink P, Schmitz PI, de Klerk MA, et al. The spectrum of antecedent infections in Guillain-Barré syndrome: a case-control study. Neurology. 1998;51(4):1110–5.
Alessandro L, Rueda JMP, Wilken M, et al. Differences between acute-onset chronic inflammatory demyelinating polyneuropathy (A-CIDP) and acute inflammatory demyelinating polyneuropathy (AIDP) in adult patients. J Peripher Nerv Syst. 2018;
Dionne A, Nicolle MW, Hahn AF. Clinical and electrophysiological parameters distinguishing acute-onset chronic inflammatory demyelinating polyneuropathy from acute inflammatory demyelinating polyneuropathy. Muscle Nerve. 2010; 41(2): 202- 207.
Van den Bergh PYK , van Doorn PA , Jacobs BC , Querol L , Bunschoten C , Cornblath DR. Boundaries of chronic inflammatory demyelinating polyradiculoneuropathy. J Peripher Nerv Syst. 2020;25(1):4–8
Querol L, Rojas-García R, Diaz-Manera J, Barcena J, Pardo J, Ortega,et-al. Rituximab in treatment-resistant CIDP with antibodies against paranodal proteins. Neurol Neuroimmunol Neuroinflamm. 2015 Sep 3;2(5):e149
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Sankalp Mohan DM , Megha Dhamne MD
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
